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Implication for health policy/practice/research/medical education:
The essential oils of C. cyminum, L. stoechas and A. sieberi showed promising antifungal effects against Malassezia strains from 
patients with Malassezia dermatitis as important fungal pathogens. Hence, these essential oils, especially C. cyminum, could be 
used to develop an effective therapy against skin infections caused by Malassezia strains.
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Introduction: The genus Malassezia is an important skin resident of human. The present study 
aimed to analyze in vitro activity of the essential oils of Lavandula stoechas, Cuminum cyminum 
and Artemisia sieberi against clinical strains of Malassezia species. 
Methods: A total of 47 Malassezia strains, including Malassezia furfur, Malassezia globosa and 
Malassezia obtuse, were used in this study. A disk diffusion technique was selected for testing the 
susceptibility of Malassezia strains to the essential oils. 
Results: All the essential oils showed in vitro activity against Malassezia strains, with M. furfur and 
M. obtusa being the highest and lowest susceptible of the strains, respectively. The highest antifungal 
activity was associated with the essential oil of C. cyminum (mean ± SD: 50.0 ± 0.0 mm), followed by 
L. stoechas (mean ± SD: 46.8 ± 3.1 mm) and A. sieberi (mean ± SD: 36.9 ± 5.7 mm). The inhibition 
zone ranges were 12.5 to 15.6 mm (mean ± SD: 14.4 ± 1.6 mm) for ketoconazole and 11.6 to 13.3 mm 
(mean ± SD: 12.4 ± 0.9 mm) for fluconazole. Although all the antifungal drugs were found to possess 
good antifungal activities against Malassezia strains, their effects were lower than the activities shown 
by the essential oils tested (P < 0.05). 
Conclusion: These results indicated that the essential oils tested, especially the one from C. cyminum, 
inhibited the growth of clinical strains of Malassezia, implying its potential use in the treatment of 
Malassezia infections. This indicates that this plant may be useful in preparation of new drugs.
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A B S T R A C T
Introduction
Members of Malassezia genus are the normal mycoflora 
on human cutaneous surfaces. They colonize the regions 
containing sebaceous glands like the head, neck and 
shoulders of humans (1). The genus of Malassezia has been 
divided into 14 various species based on the last taxonomic 
revision (2). Malassezia species are associated with a 
wide spectrum of clinical signs, such as Tinea versicolor, 
Folliculitis and Seborrheic dermatitis. It also causes 
systemic infections in immune-compromised patients (3). 
The conditions that cause Malassezia-related infections 
in humans are not fully understood but researchers 
have been able to determine the role of different factors 
including genetic and environmental factors, imbalance 
in skin normal biota, immune suppression and profuse 
sweating as agents for these infections (4).
The antifungal therapies with different drugs, especially 
azoles, are generally successful in controlling the yeast 
overgrowth, but treatment failure and rapid recurrences 
are common (5). Therefore, considering the limitations of 
currently available antifungal drugs, the search for natural 
effective drugs is justified.
Iranian plants, such as Lavandula stoechas) (known 
as Ostokhodos), C. cyminum (known as Ziree) and 
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Artemisia sieberi (known as Dermane) have been used for 
centuries as herbal remedies by local or regional subjects 
(6,7). Several reports indicated the inhibitory activities 
of essential oils of the above-mentioned plants against 
different fungal agents (8-10). This study evaluated the 
antifungal activity of L. stoechas, C. cyminum and A. 
sieberi essential oils against clinical strains of Malassezia 
from the skin of patients with Malassezia dermatitis.
Materials and Methods
Malassezia identification
Forty-seven clinical strains of Malassezia were included 
in this study. Strains of Malassezia were maintained 
on modified Dixon’s agar (Difco, USA) containing 6 g 
peptone (Oxoid), 20 g ox bile (Oxoid), 36 g malt extract, 
2 mL glycerol, 2 mL oreic acid and 12 g agar at 32oC for 
7 days. The yeasts were identified based on microscopic 
morphology and physiological characteristics, including 
catalase reaction, Tween assimilation and esculin 
hydrolysis tests to distinguish among different Malassezia 
strains (11).
Medicinal plants
Three herbal genera, such as L. stoechas, C. cyminum and 
A. sieberi, were sleeted according to the Iranian traditional 
practices (Table 1). Botanical identification was carried 
out in the herbal medicine laboratory of Shahed University 
(Tehran, Iran).
Disc-based testing
Anti-Malassezia susceptibility testing by disc diffusion 
method was carried out based on the Clinical & Laboratory 
Standards Institute (CLSI) guidelines (CLSI document 
M44-A2) and manufacturer’s instructions (12). For disc 
testing, the modified Dixon’s medium was used. The yeast 
colonies were mixed in 5 mL of sterile distilled water, and 
the turbidity was adjusted to yield 1 × 105 -1 × 106 cells/mL 
(0.5 McFarland standard). Yeast cells were inoculated on 
the agar surface using a sterile cotton swab. Subsequently, 
paper discs moistened with undiluted essential oils 
were placed on the media. In addition, discs containing 
ketoconazole and fluconazole (10 μg/disc, Master group, 
England) were placed on the media. The media were 
incubated at 32°C for 4 days and the zones of inhibition 
around the discs were measured. Disc moistened with 
sterile distilled water was considered as control. Each 
treatment was replicated twice for each sample.
Statistical analysis
Two-tailed paired student’s t test was used for analyzing 
the anti-Malassezia activities of the essential oils. A P value 
less than 0.05 was considered to be statistically significant.
Results 
As shown in Table 2, all three essential oils had inhibitory 
activities against different Malassezia strains at first 
screening. The zone diameters of yeast growth inhibition 
of the essential oils were between 15 and 50 mm. The 
highest antifungal activity was associated with the essential 
oil of C. cyminum (mean ± SD: 50.0 ± 0.0 mm), followed 
by L. stoechas (mean ± SD: 46.8 ± 3.1 mm) and A. sieberi 
(mean ± SD: 36.9 ± 5.7 mm). There were no significant 
differences among the essential oils tested against clinical 
strains of Malassezia (P > 0.05). A. sieberi essential oil 
indicated lower anti-Malassezia activity than the others.
For 46 clinical strains of Malassezia, the inhibition zone 
ranges were 12.5-15.6 mm (mean ± SD: 14.4 ± 1.6 mm) for 
ketoconazole and 11.6-13.3 mm (mean ± SD: 12.4 ± 0.9 
mm) for fluconazole. There was no significant difference 
between the standard antifungal drugs tested against 
Malassezia strains (P > 0.05).
Discussion
The antimicrobial activity of herbal plants has attracted 
much interest from scientists as a result of the growing 
problem of drug resistance among pathogenic fungi. For 
this reason, the current study was done for investigating 
the importance of herbal essential oils as anti-Malassezia 
agents. The results showed that the essential oils of 
L. stoechas, C. cyminum and A. sieberi had inhibitory 
activities against different Malassezia strains. The zone 
diameters of growth inhibition of the essential oils ranged 
from 15 to 50 mm. The highest antifungal activity was 
associated with the essential oil of C. cyminum (mean 
± SD: 50.0 ± 0.0 mm), followed by L. stoechas (mean ± 
SD: 46.8 ± 3.1 mm) and A. sieberi (mean ± SD: 36.9 ± 5.7 
mm). There were no significant differences among the 
essential oils tested against Malassezia strains. Several 
publications on antifungal activity of the essential oils 
against Malassezia species were reported in the literature 
(4,13,14). Our results are consistent with those found by 
Naeini et al (15) who reported C. cyminum being the most 
active essential oil with a mean inhibition zone of 48.3 mm 
against different Malassezia strains. Vijayakumar et al (16) 
observed inhibition zones of 5.3-30 mm by different herbal 
plants against Malassezia strains. The inhibitory and 
fungicidal activities of C. cyminum are related to the mark 
vacuolation in the cytoplasm, isolation of fibrillar layer of 
cell wall, disruption of plasma and nuclear membranes 
and a large swelling in the mitochondrial matrix (17).
Table 1. Some characteristics of the tested plants
Scientific name Voucher No. Family Local name Medicinal use Major components
Lavandula stoechas 101 Labiatae Ostokhodos Antispasmodic, carminative, wound healing Fenchone, camphor, cineole
Cuminum cyminum 1172 Apiaceae Ziree Carminative, antidiarrhoeaic, antispasmodic α-Pinene, cineole, linalool
Artemisia sieberi 1559 Compositeae Dermane Anti-septic, anti-infective α-Thujone, camphor, β-thujone
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In the present study, A. sieberi essential oil indicated lower 
anti-Malassezia activity than the others. In agreement 
with our results, Khosravi et al (14) showed that A. sieberi 
essential oil had inhibitory activity against different 
Malassezia strains, including M. pachydermatis, M. globosa, 
M. restricta, M. sloofiae, M. furfur, M. nana, M. obtuse 
and M. sympodialis. Previous studies also demonstrated 
inhibitory activity of A. sieberi essential oil against both 
yeasts (Candida spp., Rhodotorula spp., Cryptococcus spp. 
and Saccharomyces spp.) and filamentous fungi (Fusarium 
spp. and Aspergillus spp.) (18,19). In an experimental 
study conducted by Khosravi et al (20), anti-Malassezia 
activity of A. sieberi essential oil was demonstrated. The 
results exhibited the improvement rates of 71% and 
91.9% in clotrimazole and A. sieberi essential oil groups 
after 2 weeks of the treatment (P < 0.05). Also, 4 weeks 
after treatment, the definitive cure rates were achieved 
approximately 51.6% for patients receiving clotrimazole 
and 70.3% for patients receiving A. sieberi essential oil. 
It is suggested that the major components of A. sieberi 
essential oil, including α-and β-thujone, camphor and 
1,8-cineole, can be responsible for inhibiting the growth of 
saprophytic and pathogenic fungi. The exact mechanisms 
of antifungal activity are associated with oxidative stress 
induction, protein alkylation and depolarization disorder 
of the mitochondrial membrane (21).
Although no report was found concerning the effect of L. 
stoechas essential oil against Malassezia strains but several 
investigators studied on other fungi. In this context, 
Zuzarte et al (10) demonstrated the inhibitory effect 
of L. stoechas against Cryptococcus spp., Candida spp., 
Aspergillus spp. and dermatophytes. Also, the antifungal 
activity of L. stoechas essential oil from various regions of 
Algeria was previously evaluated against Candida albicans, 
Aspergillus niger and A. flavus (22). 
In this study, the mean inhibition zones were found to 
be 14.4 and 12.4 mm for ketoconazole and fluconazole, 
respectively. No statistically significant difference 
was observed between the standard antifungal drugs 
tested against Malassezia strains. In agreement with 
our observations, Strippoli et al (23) exhibited that 
ketoconazole was the most active drug against Malassezia 
strains. According to Miranda et al (24), these pathogenic 
yeasts were susceptible to all drugs tested, especially 
ketoconazole and fluconazole. Fluconazole is an effective 
antifungal drug for treating Malassezia dermatitis (25). 
Our results exhibited that fluconazole has lower activity 
than another azole. This finding is consistent with 
that of Velegraki et al (26), who showed low activity of 
fluconazole for Malassezia strains. Prophylactic therapies 
using fluconazole can be led to frequent recurrence of 
Malassezia infections. Although the antifungal drugs 
were found to possess good antifungal activity against 
Malassezia strains, their effects were lower than the 
activities shown by the essential oils tested. Previous 
studies exhibited that combination of various components 
in each essential oil has higher antifungal activity than 
each component and studies also suggested that the 
sum of essential oil components can help in potentiating 
synergistic effect (27,28).
Conclusion
In summary, the present study results showed that 
clinical strains of Malassezia had different susceptibilities 
to antifungal agents, with M. obtusa being the lowest 
susceptible of the strains. In addition, we demonstrated 
that the essential oils of L. stoechas, C. cyminum and A. 
sieberi had inhibitory activities against clinical strains of 
Malassezia, being C. cyminum essential oil as the most 
active herbal oil. These results could be used for the design 
of new antifungal agents with effective clinical importance.
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